The score rose 6 points, mainly due to valuation and price changes. Price rose 1.6%, from $59.10 to $60.04.

Valuation and price changes added 6.1 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Historical cheapness: current PE is 9.4× versus the full-history median of 12.5× shown in the valuation table, producing 68.1/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 72.6/100. The model applies a 25.1% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 14.3× (18-month half-life). The favorable scenario uses 10.9× PE and $8.8 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Business trends are strong. Over the past year: revenue -7.1%, earnings +282.4%, operating margin +3 percentage points. Free cash flow is 21.1% of revenue. The business score is 68.1/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $8.83 of EPS and a 10.9× PE, suggesting a share price of about $95.94 — 56% above today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $5.52 of EPS and a 8.9× PE, suggesting a share price of about $49.11 — 20% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.